BG104910A - Novel 1,2,5-trisubstituted 1,2-dihydroindazol-3-ones with anti-asthmatic, antiallergic, anti-inflammatory, immuno-modulating and neuro-protective effect, method for the production and use thereof as a medicament - Google Patents
Novel 1,2,5-trisubstituted 1,2-dihydroindazol-3-ones with anti-asthmatic, antiallergic, anti-inflammatory, immuno-modulating and neuro-protective effect, method for the production and use thereof as a medicamentInfo
- Publication number
- BG104910A BG104910A BG104910A BG10491000A BG104910A BG 104910 A BG104910 A BG 104910A BG 104910 A BG104910 A BG 104910A BG 10491000 A BG10491000 A BG 10491000A BG 104910 A BG104910 A BG 104910A
- Authority
- BG
- Bulgaria
- Prior art keywords
- asthmatic
- neuro
- immuno
- modulating
- ones
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/26—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19821003A DE19821003A1 (de) | 1998-05-11 | 1998-05-11 | Neue 1,2,5-trisubstituierte 1,2-dihydro-indazol-3-one mit antiasthmatischer, antiallergischer, entzündungshemmender, immunmodulierender und neuroprotektiver Wirkung, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| PCT/EP1999/002291 WO1999058504A1 (de) | 1998-05-11 | 1999-04-01 | Neue 1,2,5-trisubstituierte 1,2-dihydro-indazol-3-one mit antiasthmatischer, antiallergischer, entzündungshemmender, immunmodulierender und neuroprotektiver wirkung, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BG104910A true BG104910A (en) | 2001-06-29 |
Family
ID=7867363
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG104910A BG104910A (en) | 1998-05-11 | 2000-11-03 | Novel 1,2,5-trisubstituted 1,2-dihydroindazol-3-ones with anti-asthmatic, antiallergic, anti-inflammatory, immuno-modulating and neuro-protective effect, method for the production and use thereof as a medicament |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US6180637B1 (sk) |
| EP (1) | EP1077948A1 (sk) |
| JP (1) | JP2002514627A (sk) |
| KR (1) | KR20010025011A (sk) |
| CN (1) | CN1309642A (sk) |
| AR (1) | AR018605A1 (sk) |
| AU (1) | AU745796B2 (sk) |
| BG (1) | BG104910A (sk) |
| BR (1) | BR9911772A (sk) |
| CA (1) | CA2271837A1 (sk) |
| CO (1) | CO5021131A1 (sk) |
| DE (1) | DE19821003A1 (sk) |
| HK (1) | HK1038751A1 (sk) |
| HU (1) | HUP0101707A3 (sk) |
| IL (1) | IL139358A0 (sk) |
| NO (1) | NO20005698L (sk) |
| NZ (1) | NZ508646A (sk) |
| PL (1) | PL344254A1 (sk) |
| SK (1) | SK17082000A3 (sk) |
| TR (1) | TR200003302T2 (sk) |
| TW (1) | TW448163B (sk) |
| WO (1) | WO1999058504A1 (sk) |
| ZA (1) | ZA200006151B (sk) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6417189B1 (en) * | 1999-11-12 | 2002-07-09 | Gpi Nil Holdings, Inc. | AZA compounds, pharmaceutical compositions and methods of use |
| US7253169B2 (en) | 1999-11-12 | 2007-08-07 | Gliamed, Inc. | Aza compounds, pharmaceutical compositions and methods of use |
| WO2008141385A1 (en) * | 2007-05-21 | 2008-11-27 | Biota Scientific Management Pty Ltd | Viral polymerase inhibitors |
| JP5640162B2 (ja) | 2011-03-14 | 2014-12-10 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | ロイコトリエン生成のベンゾジオキサンインヒビター |
| WO2013012844A1 (en) | 2011-07-19 | 2013-01-24 | Boehringer Ingelheim International Gmbh | Arylpyrazole ethers as inhibitors of leukotriene a4 hydrolase |
| WO2013134226A1 (en) | 2012-03-06 | 2013-09-12 | Boehringer Ingelheim International Gmbh | Benzodioxanes for inhibiting leukotriene production |
| EP2822941B1 (en) | 2012-03-06 | 2017-05-10 | Boehringer Ingelheim International GmbH | Benzodioxanes in combination with statins for inhibiting leukotriene production |
| EP2885285B1 (en) | 2012-07-17 | 2016-10-19 | Boehringer Ingelheim International GmbH | Pyrazole drivatives which inhibit leukotriene production |
| EP3022193B1 (en) | 2013-07-15 | 2017-04-26 | Boehringer Ingelheim International GmbH | Inhibitors of leukotriene production |
| WO2015009611A1 (en) | 2013-07-15 | 2015-01-22 | Boehringer Ingelheim International Gmbh | Inhibitors of leukotriene production |
| WO2017211274A1 (en) * | 2016-06-08 | 2017-12-14 | Dong Yuhong | Lipids with odd number of carbon atoms and their use as pharmaceutical composition or nutritional supplement |
| CN113105409B (zh) * | 2021-04-06 | 2023-06-02 | 四川大学 | 2-(羟基苄基)苯并[d]异噻唑酮类化合物、其制备方法和用途 |
| AU2022376563A1 (en) | 2021-11-01 | 2023-12-07 | Alkahest, Inc. | Benzodioxane modulators of leukotriene a4 hydrolase (lta4h) for prevention and treatment of aging-associated diseases |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3132916A1 (de) * | 1981-08-20 | 1983-03-03 | Kali-Chemie Pharma Gmbh, 3000 Hannover | 1-phenylindazol-3-on-verbindungen sowie verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| US5179112A (en) * | 1985-04-17 | 1993-01-12 | Ici Americas Inc. | Heterocyclic amide derivatives and pharmaceutical use |
| IL84944A (en) * | 1987-01-19 | 1992-02-16 | Ici Plc | Pharmaceutical compositions containing 1,2-dihydro-3h-indazolone derivatives,some new such compounds and their preparation |
| US5229408A (en) * | 1988-07-15 | 1993-07-20 | Ici Pharma | 4-carbamoyl-1,2-dihydro-3H-indazol-3-one derivatives |
| US5036083A (en) * | 1988-07-15 | 1991-07-30 | Ici Pharma | Heterocyclic agents |
| DE19610882A1 (de) * | 1996-03-20 | 1997-09-25 | Dresden Arzneimittel | Neue 1,3,5-trisubstituierte Indazol-Derivate mit antiasthmatischer, antiallergischer, entzündungshemmender und immunmodulierender Wirkung, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
-
1998
- 1998-05-11 DE DE19821003A patent/DE19821003A1/de not_active Withdrawn
-
1999
- 1999-04-01 JP JP2000548308A patent/JP2002514627A/ja active Pending
- 1999-04-01 HU HU0101707A patent/HUP0101707A3/hu unknown
- 1999-04-01 AU AU42576/99A patent/AU745796B2/en not_active Ceased
- 1999-04-01 EP EP99950343A patent/EP1077948A1/de not_active Withdrawn
- 1999-04-01 NZ NZ508646A patent/NZ508646A/xx unknown
- 1999-04-01 CN CN99808515A patent/CN1309642A/zh active Pending
- 1999-04-01 SK SK1708-2000A patent/SK17082000A3/sk unknown
- 1999-04-01 BR BR9911772-0A patent/BR9911772A/pt not_active IP Right Cessation
- 1999-04-01 KR KR1020007012614A patent/KR20010025011A/ko not_active Application Discontinuation
- 1999-04-01 TR TR2000/03302T patent/TR200003302T2/xx unknown
- 1999-04-01 WO PCT/EP1999/002291 patent/WO1999058504A1/de not_active Application Discontinuation
- 1999-04-01 PL PL99344254A patent/PL344254A1/xx unknown
- 1999-04-01 IL IL13935899A patent/IL139358A0/xx unknown
- 1999-04-23 TW TW088106565A patent/TW448163B/zh not_active IP Right Cessation
- 1999-05-05 US US09/305,602 patent/US6180637B1/en not_active Expired - Fee Related
- 1999-05-07 CO CO99028290A patent/CO5021131A1/es unknown
- 1999-05-11 AR ARP990102212A patent/AR018605A1/es not_active Application Discontinuation
- 1999-05-11 CA CA002271837A patent/CA2271837A1/en not_active Abandoned
-
2000
- 2000-10-31 ZA ZA200006151A patent/ZA200006151B/en unknown
- 2000-11-03 BG BG104910A patent/BG104910A/xx unknown
- 2000-11-10 NO NO20005698A patent/NO20005698L/no not_active Application Discontinuation
-
2002
- 2002-01-17 HK HK02100376.2A patent/HK1038751A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2002514627A (ja) | 2002-05-21 |
| IL139358A0 (en) | 2001-11-25 |
| BR9911772A (pt) | 2001-02-06 |
| NO20005698D0 (no) | 2000-11-10 |
| HK1038751A1 (zh) | 2002-03-28 |
| AU745796B2 (en) | 2002-03-28 |
| TR200003302T2 (tr) | 2001-02-21 |
| SK17082000A3 (sk) | 2001-09-11 |
| EP1077948A1 (de) | 2001-02-28 |
| CA2271837A1 (en) | 1999-11-11 |
| NO20005698L (no) | 2001-01-08 |
| DE19821003A1 (de) | 1999-11-18 |
| AU4257699A (en) | 1999-11-29 |
| KR20010025011A (ko) | 2001-03-26 |
| TW448163B (en) | 2001-08-01 |
| CN1309642A (zh) | 2001-08-22 |
| CO5021131A1 (es) | 2001-03-27 |
| WO1999058504A1 (de) | 1999-11-18 |
| PL344254A1 (en) | 2001-10-22 |
| WO1999058504A9 (de) | 2000-02-03 |
| HUP0101707A2 (hu) | 2002-03-28 |
| ZA200006151B (en) | 2000-12-06 |
| US6180637B1 (en) | 2001-01-30 |
| AR018605A1 (es) | 2001-11-28 |
| NZ508646A (en) | 2002-11-26 |
| HUP0101707A3 (en) | 2002-06-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BG104812A (en) | New dihydropyrimidines | |
| MX9700885A (es) | Nuevas heteroariloxazolidinonas. | |
| MXPA03010201A (es) | Derivados de 2-piridin-ciclohexan-1,4-diamina sustituidos. | |
| BG104910A (en) | Novel 1,2,5-trisubstituted 1,2-dihydroindazol-3-ones with anti-asthmatic, antiallergic, anti-inflammatory, immuno-modulating and neuro-protective effect, method for the production and use thereof as a medicament | |
| MX9601069A (es) | Nuevas pirido /3,2-e/pirazinonas con efecto antiasmatico y procedimiento para su preparacion. | |
| CA2262566A1 (en) | Benzamidine derivatives and the use thereof as medicaments with ltb4-antagonistic effect | |
| PL344467A1 (en) | Substituted indolinones, the production thereof and their use as medicaments | |
| WO2001045678A3 (de) | Arzneimittel, verfahren zu dessen herstellung und dessen verwendung | |
| WO2002036106A3 (de) | Neue arzneimittelkompositionen auf der basis von anticholingergika und corticosteroiden | |
| HK1050524A1 (en) | Indeno-, naphtho-, and benzocyclohepta-dihydrothiazole derivatives, the production thereof and theiruse as anorectic medicaments. | |
| ZA200500526B (en) | Prodrug, medicinal utilization thereof and process for producing the same | |
| IL139359A0 (en) | Novel 1,5-and 3-0-substituted 1h-indazoles with anti-asthmatic, anti-allergic, anti-inflammatory, immuno-modulating and neuro-protective effect, method for the production and use thereof as medicaments | |
| PL350190A1 (en) | Epothilon derivatives, method for the production and the use thereof as pharmaceuticals | |
| HUP9901616A3 (en) | Novel benzofuranone derivatives, process for their production and pharmaceutical compositions of the same | |
| AU3156600A (en) | Novel epothilon derivatives, method for the production thereof and their pharmaceutical application | |
| MY128260A (en) | Cyclopentane-and-pentene-b-amino acids | |
| WO1999054315A3 (de) | Triazolone mit neuroprotektiver wirkung | |
| WO2001049654A3 (de) | Substituierte aminomethyl-phenyl-cyclohexanderivate | |
| AU7904600A (en) | Substituted piperazine derivatives, the production and use thereof as medicaments | |
| IN187760B (sk) | ||
| AU2003289176A1 (en) | 1,3-benzothiazinone derivatives, process for producing the same and use thereof | |
| AU2001260110A1 (en) | Novel LHRH-antagonists, Production and Use Thereof as Medicament | |
| BG105326A (en) | Novel benzoylguanadine derivatives with advantageous properties, method for producing them and their use in the production of medicaments | |
| HK1051845A1 (en) | Substituted 1 and 2 naphthol mannich bases | |
| HUP0200476A2 (en) | 1,3,4-oxadiazole derivatives and process for producing the same |